Loading...

Yong-Mi Kim, MD, PhD

Title(s)Associate Professor of Pediatrics
AddressCHL MailStop57
Off Campus
Los Angeles CA 90089
Phone+1 323 361 8544
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Integrin Antibody Decreases Deformability of Patient-Derived Pre-B Acute Lymphocytic Leukemia Cells as Measured by High-Frequency Acoustic Tweezers. J Ultrasound Med. 2020 Mar; 39(3):589-595. Liu HC, Gang EJ, Kim HN, Abdel-Azim N, Chen R, Abdel-Azim H, Shung KK, Kim YM. PMID: 31633840.
      View in: PubMed   Mentions: 1     Fields:    
    2. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3052-3061. Poulard C, Kim HN, Fang M, Kruth K, Gagnieux C, Gerke DS, Bhojwani D, Kim YM, Kampmann M, Stallcup MR, Pufall MA. PMID: 30733284.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Targeting PI3K Signaling in Acute Lymphoblastic Leukemia. Int J Mol Sci. 2019 Jan 18; 20(2). Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. PMID: 30669372.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    4. Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers. Sci Rep. 2018 10 24; 8(1):15708. Liu HC, Gang EJ, Kim HN, Lim HG, Jung H, Chen R, Abdel-Azim H, Shung KK, Kim YM. PMID: 30356155.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    5. The PI3Kd Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9). Adam E, Kim HN, Gang EJ, Schnair C, Lee S, Lee S, Khazal S, Kosoyan O, Konopleva M, Parekh C, Bhojwani D, Wayne AS, Abdel-Azim H, Heisterkamp N, Kim YM. PMID: 28891959.
      View in: PubMed   Mentions:
    6. CBP/Catenin antagonists: Targeting LSCs' Achilles heel. Exp Hematol. 2017 08; 52:1-11. Kim YM, Gang EJ, Kahn M. PMID: 28479420.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells. Methods Mol Biol. 2017; 1613:463-478. Duchartre Y, Kim YM, Kahn M. PMID: 28849572.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med. 2016 11; 8(11):1340-1359. Li L, Qi X, Sun W, Abdel-Azim H, Lou S, Zhu H, Prasadarao NV, Zhou A, Shimada H, Shudo K, Kim YM, Khazal S, He Q, Warburton D, Wu L. PMID: 27737899.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    9. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016 Mar; 99:141-9. Duchartre Y, Kim YM, Kahn M. PMID: 26775730.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    10. Effects of the small-molecule inhibitor of integrin a4, TBC3486, on pre-B-ALL cells. Leukemia. 2014 Oct; 28(10):2101-4. Hsieh YT, Gang EJ, Shishido SN, Kim HN, Pham J, Khazal S, Osborne A, Esguerra ZA, Kwok E, Jang J, Bonig H, Biediger RJ, Vanderslice P, Kim YM. PMID: 24903479.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    11. Role of integrin alpha4 in drug resistance of leukemia. Front Oncol. 2014; 4:99. Shishido S, Bönig H, Kim YM. PMID: 24904821.
      View in: PubMed   Mentions:
    12. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood. 2013 Mar 07; 121(10):1814-8. Hsieh YT, Gang EJ, Geng H, Park E, Huantes S, Chudziak D, Dauber K, Schaefer P, Scharman C, Shimada H, Shojaee S, Klemm L, Parameswaran R, Loh M, Kang ES, Koo HH, Hofmann WK, Andrade J, Crooks GM, Willman CL, Müschen M, Papayannopoulou T, Heisterkamp N, Bönig H, Kim YM. PMID: 23319569.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    13. The gamma catenin/CBP complex maintains survivin transcription in ß-catenin deficient/depleted cancer cells. Curr Cancer Drug Targets. 2011 Feb; 11(2):213-25. Kim YM, Ma H, Oehler VG, Gang EJ, Nguyen C, Masiello D, Liu H, Zhao Y, Radich J, Kahn M. PMID: 21158719.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells